Yan Li, Ph.D.

Photo of Yan Li
Small Business Technology Development, DEM K99/R Pathway to Independence Awards and R13 Conference Grants

Responsibilities & Activities

My grant portfolios include: (1) Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) program supporting development of therapeutic and diagnostic products (e.g., drug, device, and software) in the areas of type 2 diabetes, obesity, adipose tissue, energy balance, cystic fibrosis, neuroendocrinology, and hormone-related bone and mineral metabolism; (2) Pathway to Independence Awards (K99/R00) in the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM); and (3) DEM Scientific Conferences Grants (R13). I am also responsible for DEM R21 grants administrative management.

Research Programs

Bioengineering, Biotechnology, and Imaging as applied to Diabetes, Metabolic, and Endocrine Diseases
Cutting-edge technologies that elucidate the mechanisms underlying endocrine and metabolic diseases, including diabetes.

Cystic Fibrosis
Etiology, molecular pathogenesis, pathophysiology, diagnosis, and treatment of cystic fibrosis and its complications.

Committees & Working Groups

  • NIH Training Advisory Committee, Member
  • NIDDK Minority Affairs Advisory Committee, Member
  • NIDDK SBIR/STTR Committee, Member
  • NIDDK Obesity Research Working Group, Member
  • DEM Clinical Sciences Working Group, Member